Zantac Chronicles – Concluding Chapters in the MDL
Drug & Device Law
DECEMBER 27, 2022
Filing a citizen’s petition, Valisure shocked the FDA into an ill-advised recall by reporting that “tests found NDMA in ranitidine in excess of 3,000,000 ng [nanograms] per pill” – far above FDA’s 96 ng/day “daily limit.” The FDA recognized these results as bogus, “conclud[ing] that. . . 2022 WL 17480906, at *1.
59 
Let's personalize your content